Impact of perineal Crohn's disease on utilization of care in the absence of modifiable predictors of treatment failure

被引:2
作者
Dursun, Abdulmetin [1 ,2 ]
Hodin, Richard [1 ,2 ]
Bordeianou, Liliana [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Div Gastrointestinal Surg, Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
Perineal Crohn's disease; Anal fistula; Infliximab; Diversion for anal fistula; INFLIXIMAB INFUSION;
D O I
10.1007/s00384-014-2013-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The burden of perineal Crohn's disease (PCD) remains poorly characterized, and many patients ultimately require fecal diversion or proctectomy. Our goal was to characterize the clinical course of patients presenting with perineal Crohn's disease, focusing on the cohort of patients ultimately requiring fecal diversion, and identify modifiable predictors for this unfortunate outcome. We performed a retrospective review of 81 consecutive patients who underwent 172 operations to address complications of PCD. Diverted patients were compared to those who did not require diversion in regard to demographics, surgical procedure, postoperative infliximab, and presence of proctitis (chi square, t tests). Logistic regression was utilized to predict the need for fecal diversion. The number of visits needed to undergo care for this condition was quantified. Eight-one patients underwent a total of 172 surgical procedures and had a total of 2713 outpatient visits (range 1-118) to address symptoms of perineal Crohn's disease. Following first intervention, only 57.1 % healed at 3 months. These rates were highest in patients treated with fistulotomies and were not impacted by whether patients received postoperative infliximab (p = 0.703). Patients (23.5 %) underwent three or more surgical procedures to control their PCD and ultimately only 60 % healed without diversion, which was performed in 19 (23.5 %) patients. Patients undergoing more than three operations (OR = 10.9, p = 0.006) and women with rectovaginal fistula (OR = 3.88, p < 0.01) were at a high risk for diversion. Modifiable factors such as infliximab, smoking, proctitis, and surgery aimed at closing the internal anal opening did not alter outcome. In the patients with perineal Crohn's, complex fistulas healing rates appear to be independent of postoperative infliximab or procedures aimed at closing the internal anal opening. Those who do not heal require numerous specialist visits.
引用
收藏
页码:1535 / 1539
页数:5
相关论文
共 15 条
[1]   Predictors of Crohn's disease [J].
Beaugerie, L ;
Seksik, P ;
Nion-Larmurier, I ;
Gendre, JP ;
Cosnes, J .
GASTROENTEROLOGY, 2006, 130 (03) :650-656
[2]  
FRY RD, 1989, SURG GYNECOL OBSTET, V168, P42
[3]   Does infliximab infusion impact results of operative treatment for crohn's perianal fistulas? [J].
Gaertner, Wolfgang B. ;
Decanini, Alejandra ;
Mellgren, Anders ;
Lowry, Ann C. ;
Goldberg, Stanley M. ;
Madoff, Robert D. ;
Spencer, Michael P. .
DISEASES OF THE COLON & RECTUM, 2007, 50 (11) :1754-1760
[4]   Perianal Crohn disease - Predictors of need for permanent diversion [J].
Galandiuk, S ;
Kimberling, J ;
Al-Mishlab, TG ;
Stromberg, AJ .
ANNALS OF SURGERY, 2005, 241 (05) :796-802
[5]   Perianal Crohn's Disease: Predictive Factors and Genotype-Phenotype Correlations [J].
Kanaan, Ziad ;
Ahmad, Surriya ;
Bilchuk, Natalia ;
Vahrenhold, Crystal ;
Pan, Jianmin ;
Galandiuk, Susan .
DIGESTIVE SURGERY, 2012, 29 (02) :107-114
[6]   Anorectal Crohn's Disease [J].
Lewis, Robert T. ;
Maron, David J. .
SURGICAL CLINICS OF NORTH AMERICA, 2010, 90 (01) :83-+
[7]   CROHNS-DISEASE - ANAL LESIONS [J].
LOCKHARTMUMMERY, HE .
DISEASES OF THE COLON & RECTUM, 1975, 18 (03) :200-202
[8]   Perianal Crohn's disease and infliximab therapy [J].
McNamara, DA ;
Brophy, S ;
Hyland, JMP .
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2004, 2 (05) :258-263
[9]   Inflammatory bowel disease characteristics among African Americans, hispanics, and non-Hispanic Whites: Characterization of a large north American cohort [J].
Nguyen, GC ;
Torres, EA ;
Regueiro, M ;
Bromfield, G ;
Bitton, A ;
Stempak, J ;
Dassopoulos, T ;
Schumm, P ;
Gregory, FJ ;
Griffiths, AM ;
Hanauer, SB ;
Hanson, J ;
Harris, ML ;
Kane, SV ;
Orkwis, HK ;
Lahaie, R ;
Oliva-Hemker, M ;
Pare, P ;
Wild, GE ;
Rioux, JD ;
Yang, HY ;
Duerr, RH ;
Cho, JH ;
Steinhart, AH ;
Brant, SR ;
Silverberg, MS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05) :1012-1023
[10]   Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement [J].
Regueiro, M ;
Mardini, H .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (02) :98-103